OXFORD UNIVERSITY PRESS

Achieving Justice in Genomic Translation: Re-Thinking the Pathway to Benefit

ISBN : 9780195390384

Price(incl.tax): 
¥9,086
Author: 
Wylie Burke; Kelly A. Edwards; Sara Goering; Suzanne Holland; Susan Brown Trinidad
Pages
224 Pages
Format
Hardcover
Size
152 x 233 mm
Pub date
Oct 2011
Send mail
Print

This book explores implicit choices made by researchers, policy makers, and funders regarding who benefits from society's investment in health research. The authors focus specifically on genetic research and examine whether such research tends to reduce or exacerbate existing health disparities. Using case examples to illustrate the issues, the authors trace the path of genetics research from discovery, through development and delivery, to health outcomes. Topics include breast cancer screening and treatment, autism research, pharmacogenetics, prenatal testing, newborn screening, and youth suicide prevention. Each chapter emphasizes the societal context of genetic research and illustrates how science might change if attention were paid to the needs of marginalized populations. Written by experts in genetics, health, and philosophy, this book argues that the scientific enterprise has a responsibility to respond to community needs to assure that research innovations achieve much needed health impacts.

Index: 

1. Making Good on the Promise of Genetics: Justice in Translational Science
Sara Goering, Suzanne Holland, and Kelly A. Edwards
2. The Social, Political, and Economic Underpinnings of Biomedical Research and Development: A Formidable Status Quo
Patricia Kuszler
3. The Input-Output Problem: Whose DNA Do We Study, and Why Does It Matter?
Stephanie Malia Fullerton
4. The Autism Genetic Resource Exchange: Changing Pace, Priorities, and Roles in Discovery Science
Holly K. Tabor and Martine Lappe
Commentary on the Discovery Phase of Research
Sara Goering, Suzanne Holland, and Kelly A. Edwards
5. Early Assessment of Translational Opportunities
Patricia Deverka and David L. Veenstra
6. The power of knowledge: How carrier and prenatal screening altered the clinical goals of genetic testing
Commentary on the Development Phase of the Translational Cycle
7. Integrating genetic tests into clinical practice: The role of guidelines
Anne-Marie Laberge and Wylie Burke
8. Genomics and the Health Commons
Nora Henrikson and Wylie Burke
Commentary on the Delivery Phase of the Translational Cycle
Sara Goering, Suzanne Holland, and Kelly A. Edwards
9. The Role of Advocacy in Newborn Screening
Catharine Riley and Carolyn Watts
10. What Outcomes? Whose Benefits?
Wylie Burke and Nancy Press
Commentary on the Outcomes Phase of the Translational Cycle
Sara Goering, Suzanne Holland, and Kelly A. Edwards
11. Bringing the "Best Science" to Bear on Youth Suicide: Why Community Perspectives Matter
Rosalina James and Helene Starks
12. Conclusion
Kelly A. Edwards, Sara Goering, Suzanne Holland and Maureen Kelley

About the author: 

Wylie Burke, MD, PhD, is Professor and Chair of the Department of Bioethics and Humanities at the University of Washington, Seattle, WA. ; Kelly Edwards, PhD, is an Associate Professor in the Department of Bioethics and Humanities, Core Faculty in the Institute for Public Health Genetics.; Sara Goering, PhD, is Assistant Professor of Philosophy and member of the Program on Values in Society and the Program on Disability Studies at the University of Washington, Seattle, WA.; Suzanne Holland, PhD, is Professor of Ethics & Religion and Philip M. Phibbs Research Scholar at University of Puget Sound in Tacoma, WA.; Susan Trinidad, MA, is a qualitative researcher in the Department of Bioethics and Humanities and a co-investigator with the Center for Genomics and Healthcare Equality.

The price listed on this page is the recommended retail price for Japan. When a discount is applied, the discounted price is indicated as “Discount price”. Prices are subject to change without notice.